Natalie Thovmasian PhD

Natalie Thovmasian is a vice president at Lumanity. Her expertise and passion are in oncology. She has extensive experience in pipeline and disease area strategy, competitive landscaping, BD&L and opportunity assessments, and brand planning. She has deep knowledge across solid tumors and hematologic malignancies, regularly attending major oncology conferences since 2016. Her work spans therapeutics modalities including cell therapy, radiopharmaceuticals, drug conjugates, immunotherapy, and small molecules. She also oversees Lumanity’s PROPEL program to introduce advanced degree candidates to life sciences strategy consulting.

Prior to Lumanity, Natalie was a member of the Business Development team at Boston Children’s Hospital in the Technology and Innovation Development Office. In this role, she helped create academic-private partnerships and advance the commercialization of intellectual property.

Outside of work, Natalie enjoys running, traveling, spending time outdoors with her husband and their two Bernese Mountain dogs, and volunteering in her community.

Natalie received a BS in Biochemistry from Creighton University and a PhD in Biological and Biomedical Sciences from Harvard University.